GARDEN-TIMI 74 is a phase 2 trial testing the effect of ponsegromab, a novel monoclonal antibody directed against growth differentiation factor (GDF)-15, on health status and physical activity in patients with heart failure and elevated circulating GDF-15 concentrations. GARDEN on ClinicalTrials.gov CONTACT US about GARDEN